DBS for Depression
NCT: NCT03437928 · RECRUITING
Brief Summary
The goal of the study is to address the unmet need of TRD patients by identifying brain networks critical for treating depression and to use next generation precision DBS with steering capability to engage these targeted networks. The study's goal will be achieved through 3 specific aims: 1. Demonstrate device capability to selectively and predictably engage distinct brain networks 2. Delineate depression-relevant networks and demonstrate behavioral changes with network-targeted stimulation 3. Demonstrate that chronic DBS using steered, individualized targeting is feasible and safe for reducing depressive symptoms
Frequently Asked Questions
What is DBS for Depression?
DBS for Depression is a clinical trial registered under NCT03437928. Current status: RECRUITING.
What is the status of NCT03437928?
The current status of NCT03437928 (DBS for Depression) is: RECRUITING.
When did DBS for Depression start?
DBS for Depression started on 2019-08-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.